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ABSTRACT 
Background and Objectives: Percutaneous coronary intervention for chronic total occlusion lesions is technically 
difficult despite equipment advances. Changes in electrocardiographic patterns, such as Q and T waves, during 
chronic total occlusion can provide information about procedural success and myocardial viability. In this study, we 
investigated clinical, electrocardiographic, and procedural characteristics of chronic total occlusions. Subjects and 
Methods: Patients (2,635) who underwent coronary angiography between January 2006 and July 2007 at six Ca-
tholic University Hospitals were identified using a dedicated Internet database. Results: A total of 195 patients had 
total occlusion lesions (7.4%). Percutaneous coronary interventions were attempted in 136 total occlusion lesions 
(66.0%) in 134 patients. Successful recanalization with stent implantation was accomplished in 89 lesions, with a 
procedural success rate of 66.4%. One procedure-related death occurred because of no-reflow phenomenon. After 
excluding 8 patients with bundle branch block, Q and T wave inversions were observed in 60 (32.1%) and 78 patients 
(41.7%), respectively. The presence of Q waves was associated with severe angina, decreased left ventricular ejection 
fraction, regional wall motion abnormality, and T wave inversion, but was not related to procedural success. Con-
clusion: Percutaneous coronary intervention is a safe and useful procedure for the revascularization of coronary 
chronic total occlusion lesions. The procedural success rate was not related to the presence of pathologic Q waves, 
which were associated with severe angina and decreased left ventricular function. (Korean Circ J 2009;39:111-115) 
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Introduction 
 
Percutaneous coronary intervention (PCI) of chronic 
total occlusion (CTO) lesions has a low success rate and 
is technically difficult regardless of operator experience 
and despite advances in equipment. CTO treatment re-
mains a major challenge and is a frequent reason for pa-
tient referral for coronary artery bypass surgery (CABG), 
leading some to refer to the treatment as the “last fron-
tier” of PCI.
1)2) However, CTOs account for 10% of all 
PCI,
3) with the majority of patients treated with either 
CABG or medical therapy. The choice of therapy de-
pends on center policies and operator experience. Se-
veral studies performed during the bare metal stent 
(BMS) era showed high rates of restenosis (32-55%) and 
re-occlusion (8-12%).
4)5) Drug-eluting stents are safe 
and effective in this challenging lesion subset because 
they markedly reduce the incidence of restenosis and 
the need for target lesion revascularization.
6-9) Several 
retrospective observational studies have reported the 
clinical impact of successful percutaneous CTO revas-
cularization on long-term survival.
10) Other studies have 
demonstrated statistically significant improvements in 
left ventricular function and regional wall motion with 
successful CTO recanalization.
11-13) 
Electrocardiogram (ECG) is performed for almost all 
patients who undergo cardiologic evaluation. In old Q 
wave myocardial infarctions, persistent negative T wave 
inversion in infarction-related leads (IRL) is associated 
with transmural infarction with a thin fibrotic layer,
14-16) 
and normalization of the T wave can identify viable myo-
cardium.
17) The absence of a Q wave, which confers the 
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non-existence of a previous myocardial infarction, is a 
predictor of improved left ventricular systolic function 
after successful recanalization of the CTO.
18) 
Here, we analyzed the clinical and angiographic cha-
racteristics and trends in revascularization and the treat-
ment of CTOs at the six hospitals in the Catholic Med-
ical Center, Korea, between January, 2006, and July, 
2007. We also analyzed Q and T wave patterns, which 
predict myocardial viability, in CTO patients. 
 
Subjects and Methods 
 
Demographic and procedural data for all patients 
undergoing coronary angiography at Catholic Medical 
Center were prospectively entered into a dedicated in-
ternet database. All data, including age, gender, medical 
history, coronary angiographic results, ejection fraction, 
and treatment recommendations, were prospectively 
collected at the time of cardiac catheterization. All ch-
ronically occluded vessels observed between January 2006, 
and July 2007, were retrospectively identified. Patients 
with previous bypass surgery or recent (<3 months) 
myocardial infarction were excluded. 
Significant coronary disease was defined as  ≥1 lesion 
of  ≥70% luminal diameter stenosis. Total coronary 
artery occlusion was defined as 100% luminal diameter 
stenosis without a discernable lumen and the absence 
of anterograde flow. CTO was defined as total coronary 
artery occlusion of ≥1 month in duration. Multivessel 
disease was defined as ≥70% stenosis in ≥2 vessels. 
Before the procedure, all patients were treated with 
a loading dose of  ≥300 mg clopidogrel and 100 mg 
aspirin. At the start of the procedure, patients received 
a single bolus of unfractionated heparin (80-120 U/kg 
body weight). Procedures were performed using a stand-
ard femoral approach. In more than 90% of cases, guide-
wires with microcatheter support were used to cross the 
lesion, but newer techniques were also attempted, such 
as intravascular ultrasound (IVUS)-guided manipulation 
of the guidewire. Procedural success was defined as re-
duction of residual lumen diameter stenosis to <50% 
and successful stent employment in the CTO segment 
without a major adverse cardiac event (MACE). MACE 
consisted of in-hospital death, myocardial infarction, 
urgent or emergent CABG, or a cerebrovascular event. 
An ECG was performed at the time of admission for 
coronary intervention. The presence of a Q wave ≥30 
msec in leads III and aVF was regarded as the Q wave 
area in right coronary artery occlusion, while the pre-
sence of a Q wave ≥30 msec or R waves ≤20 mV in 
leads V3 and V4 was defined as the Q wave area in left 
anterior descending artery occlusion. Q waves longer 
than 30 msec in two or more leads of V5, V6, and aVL, 
were defined as the Q wave area in left circumflex artery 
occlusion. Patients with left or right bundle branch block 
(QRS duration  ≥120 msec) were excluded from ECG 
analysis. In-hospital and 30-day clinical data were also 
accessed from the internet registry. 
 
Statistical analysis 
Discrete variables are presented as percentages and 
compared with the Fischer’s exact test. Continuous vari-
ables are expressed as mean±SD and compared using 
the Student’s t-test. 
 
Results 
 
Between January 2006, and July 2007, 2,635 patients 
underwent coronary angiograms and 195 had at least 
one CTO (7.4%). Eleven patients had 2 CTO lesions, 
giving a total of 206 detected CTO lesions. The baseline 
demographics of the patients are presented in Table 1. 
About half of the patients had 3-vessel disease, and 
CTOs were most commonly observed in the right coro-
nary arteries (Table 2). 
PCI was not attempted in 61 patients: 58 patients 
decided to only take medication and 3 patients were 
referred for CABG. Recanalization using PCI was at-
tempted in 134 patients for 136 CTO lesions. Success-
ful recanalization with stent implantation was accom-
plished in 89 patients and 89 CTO lesions, giving a 
procedural success rate of 66.4% (Table 2). 
Recanalization was most frequently attempted for 
CTO of the left anterior descending artery. In most 
cases, coronary lesion passage was initially attempted 
with a soft guidewire with microcatheter support. CTO 
lesion passage was accomplished in 61 cases (success 
Table 1. Baseline characteristics (n=195) 
  No (%) 
Sex (M：F) 141：54 (72：28) 
Age, year  62.6±11.3 
Diabetes 80  (41.0) 
Hypertension 118  (60.5) 
Current smoker  48 (24.6) 
CCS class III or IV angina  56 (28.4) 
Creatinine >1.3 mg/dL  35 (17.9) 
Total cholesterol >200 mg/dL  63 (32.3) 
Triglyceride >150 mg/dL  55 (28.2) 
LVEF measured by echocardiography   
≤40% 27  (14.6) 
>40% 142  (76.8) 
Not available  16 (8.7) 
Left ventricular RWMA   
Yes 68  (36.8) 
No 101  (54.5) 
Not available  16 (8.7) 
CCS: Canadian Cardiovascular Society classification system for an-
gina, LVEF: left ventricular ejection fraction, RWMA: regional wall
motion abnormality    
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rate: 44.1%). In 3 cases, guidewires with stiffer tips were 
used initially. In the remaining 72 cases, coronary guide-
wires with stiffer tips were subsequently used to cross 
over the CTO lesion, and lesion crossing was accom-
plished in 28 cases. After adequate balloon dilatation, 
stent implantation was attempted. Sirolimus-eluting cor-
onary stents (SES) (Cypher
TM stent, Cordis Johnson and 
Johnson, Miami, FL, USA) were the most common stent. 
One patient died during the procedure due to no-reflow 
phenomenon (Table 2). 
Failure of guidewire crossover through the CTO le-
sion was the most common reason for unsuccessful pro-
cedures (38 CTO lesions: 80.9%). In 8 cases (17%), the 
stent could not pass the CTO lesion although balloon 
dilatation was successful. Unacceptable engagement of 
the guiding catheter was the reason for failure in one 
CTO lesion (2.1%). 
Eight patients were excluded from the ECG analysis 
because they had bundle branch block. More than 90% 
of patients had regular sinus rhythm (n=181, 96.8%), 
and atrial fibrillation was observed in 6 patients (Table 
3). The presence of a Q wave was related to more severe 
anginal symptoms according to the Canadian Cardio-
vascular Society (CCS) classification system for angina; 
decreased left ventricular ejection fraction and regional 
wall motion abnormality were observed by echocardio-
graphy (p<0.01), but other clinical and laboratory find-
ings did not differ whether the patients had Q waves 
or not. The Q wave was not related to the procedural 
success rate (p=0.55) (Table 4). 
 
Discussion 
 
Here we measured the clinical, electrocardiographic, 
and procedural characteristics of CTO lesions in multi-
ple Korean centers. While the technical and procedural 
success rates of PCI in CTOs have steadily increased 
over the last 15 years because of greater operator expe-
rience and improvements in equipment and procedural 
techniques,
19)20) PCI of CTO lesions still has a low suc-
cess rate and is technically difficult. In a series of 1,074 
consecutive patients undergoing PCI, the primary suc-
cess rate was 90% in non-occluded lesions, 78% in 
functional total occlusions {Thrombolysis in Myocar-
dial Infarction (TIMI) flow grade 1}, and 63% in true 
CTOs.
21) Contemporary series found procedural success 
Table 2. Angiographic and procedural characteristics of chronic
total occlusion lesions 
  No (%) 
Number of diseased vessels   
Single 33  (16.9) 
Multi 162  (83.1) 
CTO vessel   
LAD 62  (30.1) 
LCX 44  (21.4) 
RCA 99  (48.0) 
Ramus 1  (0.5) 
Target vessel of the lesion   
LAD 41  (46.1) 
LCX 17  (19.1) 
RCA 31  (34.8) 
Reference diameter (mm)  3.00±0.32 
Lesion length (mm)  32.66±16.80 
Guidewire that accomplished successful 
lesion passage (n=97) 
 
Soft wire  30 (30.9) 
Choice PT
TM   33  (34.0) 
Stiff wire  34 (35.1) 
Number of implanted stents  1.5±0.8 
Implanted stents (n=135)  
Cypher
TM 92  (68.1) 
Taxus
TM 29  (21.5) 
Endeavor
TM 14  (10.4) 
CTO: chronic total occlusion, LAD: anterior descending coronary
artery, LCX: left circumflex artery, RCA: right coronary artery,
MACE: major adverse cardiac event 
 
Table 3. Electrocardiographic patterns in chronic total occlusion 
patients 
  No (%) 
Sinus rhythm  181 (96.8) 
Atrial fibrillation  6 (3.2) 
Absence of Q wave and positive T wave  96 (51.3) 
Absence of Q wave and T wave inversion  41 (21.9) 
Q wave and positive T wave  23 (12.3) 
Q wave and T wave inversion  27 (14.5) 
 
Table 4. Clinical, laboratory, and procedural characteristics ac-
cording to the presence of a Q wave 
  Q wave 
n=60 (%) 
Absence of   
Q wave 
n=127 (%) 
p 
Age, years  61.3±12.6 62.7±10.8 NS 
Male  43 (71)  91 (71)  NS 
CCS III or IV symptom  26 (43)  22 (17)  p<0.01 
DM  22 (37)  51 (40)  NS 
Hypertension  37 (62)  72 (57)  NS 
Current smoker  15 (25)  33 (26)  NS 
Cr ≥1.3 mg/dL  10 (17)  23 (18)  NS 
TC ≥200 mg/dL  18 (30)  45 (35)  NS 
TG ≥150 mg/dL  16 (27)  35 (28)  NS 
EF 48.1±11.4 56.9±11.5 p<0.01 
RWMA  36 (64)  28 (24)  p<0.01 
T wave inversion  37 (62)  41 (32)  p<0.01 
Procedural success rate    26 (70.2)  56 (64.8)  0.55 
CCS: Canadian Cardiovascular Society classification system for an-
gina, DM: diabetes mellitus, Cr: creatinine, TC: total cholesterol, 
TG: triglyceride, EF: left ventricular ejection fraction, RWMA: re-
gional wall motion abnormality 
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rates from 55% to 80%, with the variability reflecting 
differences in operator technique and experience, av-
ailability of advanced guidewires, CTO definition, and 
case selection.
2)3)10) 
We sampled subjects for a year and a half beginning 
in Jan, 2006, when the internet-based coronary artery 
database from Catholic Medical Center became avail-
able. Drug-eluting stents (DESs) became commercially 
available in March, 2003, in Korea. Thus, bare metal 
stents were not used in this study. The SES (Cypher
TM 
stent, Cordis Johnson and Johnson, Miami, FL, USA) 
was most common DES, in part because it was available 
sooner than other DESs. In this study, the operator chose 
the coronary stent. 
The most common cause of the inability to cross the 
lesion was failure to traverse the lesion with a guidewire, 
which occurred at a similar percentage as previously 
reported.
22) The success rate for percutaneous CTO re-
canalization has improved over the last five years due to 
the introduction of stiffer, more powerful, and more 
supportive wires with greater torque responses.
2) In this 
study, we observed that a guidewire with a soft tip cros-
sed the CTO lesion in almost 70% of cases when the 
operator was accustomed to manipulating the guidewire 
and when the backup power was increased using a mi-
crocatheter. The procedural success of CTO was partic-
ularly dependent on operator skill and on case selec-
tion; therefore, every operator should be accustomed to 
manipulating the guiding catheter and guidewire and 
the coronary angiogram should be reviewed carefully 
to identify anatomical structures, including collateral 
flows, before the CTO procedure. 
Although the procedural success rate was similar to 
that in previous studies, MACE occurred in only one 
patient during the procedure, perhaps due to differ-
ences in defining MACE. However, this finding also 
suggests that PCI for CTO is a safe treatment choice 
when the operator is comfortable with procedure and 
the case is carefully selected. Many new techniques and 
devices have improved the success rate of CTOs recan-
alization.
23)24) Although successful PCI for CTO lesions 
confers a long-term clinical advantage,
24) controversies 
remain whether all CTOs should be recanalized. 
Various ECG parameters, such as T wave normaliza-
tion, help assess myocardial viability or recovery of func-
tion.
17) We could not examine whether negative T waves 
were normalized because our study was observational 
in nature, using a internet-based registry in which fol-
low-up data were not available. The absence of a Q wave 
predicts improved LV systolic function after successful 
recanalization of CTO.
18) Also, ECG before PCI can pre-
dict the functional outcome of intervention for CTO. Ac-
cording to our data, CTO patients with Q waves showed 
more severe angina symptoms (CCS class III or IV); how-
ever, previous studies reported that LV function was less 
likely to improve in these patients after successful PCI.
25) 
Thus, CTO patients with Q waves cannot be helped by 
successful PCI for CTOs. However, our study also sug-
gests that improved LV function can be expected in 
more than half of patients after successful PCI for CTO 
lesions based on ECG patterns. The procedural success 
rate was not influenced by ECG patterns. 
This study has several limitations. The most impor-
tant limitation is that this is only an observational 
study based on data in an internet-based registry. Also, 
predictors of long-term survival or procedural success 
cannot be explained in this study. The results of this 
study were also influenced by differences in selection 
criteria, operator experience, and technique among the 
participating centers. 
These data represent a multicenter series of consec-
utive patients with CTO in Korea. A relatively high suc-
cess rate with a low incidence of complications was ob-
served, indicating that further standardization of proce-
dures, especially of guidewire manipulation, will improve 
the rate of successful PCI for CTO. PCI for CTO should 
be seriously considered in selected CTO patients for 
better clinical outcomes. Furthermore, all operators who 
perform PCI for CTO should be accustomed to new 
devices and techniques, such as the TornusTM cathe-
ter or the retrograde approach,
2)23)24) to improve the suc-
cess rate of the procedure. 
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